This course enables you to gain a fundamental knowledge of how drugs act at the molecular and cellular level, and how biotechnological techniques are used to produce new drugs.
This is the only Master's course in the UK which combines the subject areas of Pharmacology and Biotechnology. The aim of the course is to provide you with a firm knowledge base to understanding the fundamental aspects of these two distinct areas, with particular reference to the molecular mechanism of drugs actions or to biotechnology applications for diseases.
The course gives you
- up-to-date knowledge of the cellular and molecular pathology of various human diseases
- the basis of therapeutic rationales for treating diseases and their development
- an advanced understanding of recombinant DNA technology and how it is used to produce drugs
- experience of the latest practical techniques, such as cell culture, quantitative PCR analysis, cloning, western blotting, and analytical techniques such as HPLC and mass spectrometry
- the transferable and research skills to enable you to continue developing your knowledge and improve your employment potential.
Practical work is carried out in our teaching laboratories which contain industry standard equipment for cell culture, quantitative nucleic acid and protein analysis and a sophisticated suite of analytical equipment such as HPLC and gas chromatography. In addition, many of our research facilities such as flow cytometry, confocal microscopy, and mass spectrometry are used in taught modules and research projects and our tutors are experts in these techniques.
2018 entry requirements
For this course, a relevant degree would be any bioscience-related degree, such as biomedical science, biochemistry, biological science, especially those with pharmacology, biomedical, cell biology, molecular biology, biotechnology or disease-mechanisms content. Applicants from Medicine, Veterinary or Dentistry sciences are also encouraged to apply.
If English is not your first language you will need an IELTS score of 6.0 with a minimum of 5.5 in all skills, or a recognized equivalent. IfCore modules may include:
- Cell biology
- Fundamentals of pharmacology
- Molecular biology
- Professional development
- New approaches to pharmacology
- Research methods and statistics
During this project, you apply your skills and knowledge directly to current research into pharmacology or biotechnology or a combination of both. Practical work will give you a direct experience of performing pharmacology or biotechnology experiments using industry standard equipment for cell culture, quantitative nucleic acid determination, imaging by confocal microscopy and flow cytometry. You will be working alongside tutors within the Biomolecular Sciences Research Centre to undertake research into cancer, musculoskeletal diseases, human reproduction, neurological disease, medical microbiology and immunological basis of disease.
Optional modules may include:
- Applied biomedical techniques
- Cellular and molecular basis of cancer
- Pharmaceutical drug development
- Human genomics and proteomics
The course improves your career prospects in areas of:
- biomedical sciences
- medical research in universities and hospitals
- the pharmaceutical industry
- biotechnology companies
- government research agencies.
You also develop the skills to carry out research to Ph.D. level in pharmacology and biotechnology.
Recent MSc Pharmacology and Biotechnology graduates jobs include:
- project specialist at PAREXEL
- quality assurance documentation assistant at Vifor Pharma
- Ph.D. at the University of Manchester
- clinical research associate at AstraZeneca
- workplace services analyst at Deloitte India (Offices of the US)
- regulatory compliance specialist for Selerant
- senior product executive at PlasmaGen BioSciences.
Duration and fees
- Start dates: September
- Duration: 12 months
EU students 2018/19 academic year £6,590 for the course
International students 2018/19 academic year £13,250 for the course
- Deadline: Request info
This school offers programs in:
Last updated September 5, 2018